Deoxynivalenol-induced cytotoxicity, cytokines and related genes in unstimulated or lipopolysaccharide stimulated primary porcine macrophages

The cytotoxicity of deoxynivalenol (DON) as well as the induction of cytokines and related genes was investigated in porcine pulmonary alveolar macrophages (PAM) in absence or presence of lipopolysaccharides (LPS). IC(20) values were 1.1, 0.4 and 1.0microM DON in the MTT, neutral red and alamar blue assay, respectively, and did not differ significantly in the presence of LPS. The mRNA expression of tumour necrosis factor (TNF)-alpha peaked at 3h, whereas LPS and DON showed synergistic effects resulting in an approximately 20-fold increase at 500nM DON as compared to untreated controls. The supernatant concentrations of TNF-alpha showed similar synergistic effects. The expression of interleukin (IL)-1beta was significantly induced by DON (except for 12h) and LPS. An induction of the mRNA expression of IL-6 by DON was evident only at 3h, whereas the supernatant concentrations of LPS stimulated PAM incubated with 500nM DON were significantly decreased at most time points. Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression did not seem to contribute to the effects of DON in porcine macrophages. The results of the present investigation suggest a contribution of cytokines, especially TNF-alpha and IL-1beta, induced by DON in porcine macrophages to the effects observed in vivo.

Medienart:

E-Artikel

Erscheinungsjahr:

2009

Erschienen:

2009

Enthalten in:

Zur Gesamtaufnahme - volume:184

Enthalten in:

Toxicology letters - 184(2009), 2 vom: 30. Jan., Seite 97-106

Sprache:

Englisch

Beteiligte Personen:

Döll, Susanne [VerfasserIn]
Schrickx, Jan A [VerfasserIn]
Dänicke, Sven [VerfasserIn]
Fink-Gremmels, Johanna [VerfasserIn]

Links:

Volltext

Themen:

Cytokines
Deoxynivalenol
Interleukin-1beta
JT37HYP23V
Journal Article
Lipopolysaccharide, Escherichia coli O111 B4
Lipopolysaccharides
Research Support, Non-U.S. Gov't
Trichothecenes
Tumor Necrosis Factor-alpha

Anmerkungen:

Date Completed 17.03.2009

Date Revised 27.06.2016

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.toxlet.2008.10.024

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM184668352